KI-Beratung Beta

Produktbild: Structural Biology in Drug Discovery

Structural Biology in Drug Discovery Methods, Techniques, and Practices

Fr. 369.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

05.02.2020

Herausgeber

Jean-Paul Renaud

Verlag

John Wiley & Sons

Seitenzahl

688

Maße (L/B/H)

28.6/22.4/3 cm

Gewicht

1720 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-118-68101-5

Beschreibung

Rezension

"The book ... is a surprisingly comprehensive, monumental collection of chapters by a number of researchers in the field of drug discovery. ... [Editor Jean-Paul] Renaud was able to see the broad crucial aspects of the field and therefore able to invite excellent scientists to coauthor this book and cover so many aspects and in so much depth." -- Crystallography Reviews, March 2022

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

05.02.2020

Herausgeber

Jean-Paul Renaud

Verlag

John Wiley & Sons

Seitenzahl

688

Maße (L/B/H)

28.6/22.4/3 cm

Gewicht

1720 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-118-68101-5

Herstelleradresse

Wiley-VCH GmbH
Boschstrasse 12
69469 Weinheim
DE
product_safety@wiley.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Structural Biology in Drug Discovery
  • List of Contributors

    Preface

    Chapter 01: The Evolving Role of Structural Biology in Drug Discovery

    Chapter 02: A Structural View on Druggability: Experimental and Computational Approaches

    Chapter 03: Structural Chemogenomics: Profiling Protein-Ligand Interactions in Polypharmacological Space

    Chapter 04: Fragment-Based Ligand Discovery

    Chapter 05: Combining Structural, Thermodynamic and Kinetic Information to Drive Hit-to-Lead Progression

    Chapter 06: Allostery as Structure-Encoded Collective Dynamics: Significance in Drug Design

    Chapter 07: Biophysical Assessment of Target Protein Quality in Structure-Based Drug discovery

    Chapter 08: An Industrial Perspective on Protein-Ligand Complex Crystallization

    Chapter 09: Membrane Protein Crystallization

    Chapter 10: High-throughput Macromolecular Crystallography in Drug Discovery: Evolving in the Midst of Revolutions

    Chapter 11: Assessment of Crystallographic Structure Quality and Protein - Ligand Complex Structure Validation

    Chapter 12: Complementary Information from Neutron Crystallography Studies

    Chapter 13: Determination of Protein Structure and Dynamics by NMR: State of the Art and Application to the Characterization of Biotherapeutics

    Chapter 14: NMR Studies of Protein - Small Molecule Interactions for Drug Discovery

    Chapter 15: Computational Structural Biology for Drug Discovery: Power and Limitations

    Chapter 16: The Role of Structural Biology in Kinase Inhibitors Drug Discovery Success

    Chapter 17: Serine Proteinases from the Blood Coagulation Cascade

    Chapter 18: Epigenetic Proteins as Emerging Drug Targets

    Chapter 19: Impact of Recently Determined Crystallographic Structures of GPCRs on Drug Discovery

    Chapter 20: Targeting Protein-Protein Interactions Perspective

    Chapter 21: Mass Spectrometry-Based Strategies for Therapeutic Antibodies Extensive Characterization and Optimization (OptimAbs)

    Chapter 22: Integrating Evolution of Drug Resistance into Drug Discovery: Lessons from the Viral Proteases of HIV-1 and HCV

    Chapter 23: A Comprehensive Review on Mycobacterium Tuberculosis Targets and Drug Development from a Structural Perspective

    Chapter 24: Using Crystal Structures of Drug-Metabolizing Enzymes in Mechanism-Based Modeling for Drug Design

    Chapter 25: Intrinsically Disordered Proteins (IDPs): Targets for the Future?

    Chapter 26: Cryo-electron Microscopy as a Tool for Drug Discovery in the Context of Integrative Structural Biology

    Chapter 27: Application of Hard-X-ray Free-electron Lasers for Static and Dynamic Processes in Structural Biology